| pubmed-article:15033756 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15033756 | lifeskim:mentions | umls-concept:C0023434 | lld:lifeskim |
| pubmed-article:15033756 | lifeskim:mentions | umls-concept:C0162638 | lld:lifeskim |
| pubmed-article:15033756 | lifeskim:mentions | umls-concept:C0334227 | lld:lifeskim |
| pubmed-article:15033756 | lifeskim:mentions | umls-concept:C0132555 | lld:lifeskim |
| pubmed-article:15033756 | lifeskim:mentions | umls-concept:C0281603 | lld:lifeskim |
| pubmed-article:15033756 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:15033756 | lifeskim:mentions | umls-concept:C0071649 | lld:lifeskim |
| pubmed-article:15033756 | pubmed:dateCreated | 2004-3-22 | lld:pubmed |
| pubmed-article:15033756 | pubmed:abstractText | Downregulation of iNOS and NO is a pathway common for flavones and polyphenols, two distinct families of phytoalexins. Our data suggest that inhibition of the NO pathway could be one of the mechanisms involved in the proapoptotic properties of these phytoalexins in leukemia B-cells. | lld:pubmed |
| pubmed-article:15033756 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15033756 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15033756 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15033756 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:15033756 | pubmed:issn | 0077-8923 | lld:pubmed |
| pubmed-article:15033756 | pubmed:author | pubmed-author:DauzonneDanie... | lld:pubmed |
| pubmed-article:15033756 | pubmed:author | pubmed-author:BillardChrist... | lld:pubmed |
| pubmed-article:15033756 | pubmed:author | pubmed-author:KernCatherine... | lld:pubmed |
| pubmed-article:15033756 | pubmed:author | pubmed-author:KolbJean-Pier... | lld:pubmed |
| pubmed-article:15033756 | pubmed:author | pubmed-author:Ajchenbaum-Cy... | lld:pubmed |
| pubmed-article:15033756 | pubmed:author | pubmed-author:TangRuopingR | lld:pubmed |
| pubmed-article:15033756 | pubmed:author | pubmed-author:QuineyClaireC | lld:pubmed |
| pubmed-article:15033756 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15033756 | pubmed:volume | 1010 | lld:pubmed |
| pubmed-article:15033756 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15033756 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15033756 | pubmed:pagination | 381-3 | lld:pubmed |
| pubmed-article:15033756 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:meshHeading | pubmed-meshheading:15033756... | lld:pubmed |
| pubmed-article:15033756 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:15033756 | pubmed:articleTitle | The inducible NO synthase is downregulated during apoptosis of malignant cells from B-cell chronic lymphocytic leukemia induced by flavopiridol and polyphenols. | lld:pubmed |
| pubmed-article:15033756 | pubmed:affiliation | INSERM E355, Centre Biomédicale des Cordeliers, Paris, France. christian.billard@bhdc.jussieu.fr | lld:pubmed |
| pubmed-article:15033756 | pubmed:publicationType | Journal Article | lld:pubmed |
